Dual Incretin Synergism
Simultaneous activation of two metabolic pathways yields superior weight loss results compared to single GLP-1 agents.
Photo 1 of 3
Weight Loss & Appetite
The next-generation dual GLP-1/GIP receptor agonist. Clinically proven to deliver powerful, predictable weight loss by suppressing cravings, optimizing glucose control, and accelerating fat breakdown without gastrointestinal distress.
Combines GLP-1 and GIP receptor agonism for smooth, uninterrupted appetite suppression and zero food noise.
Eliminates blood sugar spikes, energy crashes, and intense late-night sugar cravings throughout your day.
Accelerates visceral and subcutaneous fat oxidation while preserving functional lean muscle mass.
5.400.000 IDR
Save with a bundle ↗60 mg per pen | Up to 12 weeks of use
Dual GLP-1 + GIP Receptor Agonist
Tirzepatide represents a major evolution in weight management technology. By activating both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors simultaneously, Tirzepatide creates a profound synergistic effect. GIP activity enhances fat metabolism and improves gastrointestinal tolerance, allowing for significantly higher fat loss with far fewer side effects like nausea or digestive slowness.
Simultaneous activation of two metabolic pathways yields superior weight loss results compared to single GLP-1 agents.
Silences psychological food cravings and emotional snacking within hours of your first dose.
GIP receptor signaling buffers against the gastrointestinal side effects commonly seen with older weight-loss protocols.
3 Pathways to Predictable Weight Loss
Delays gastric emptying and signals satiety directly to the brain’s hypothalamus, helping you feel comfortably full with smaller meal portions.
Stimulates GIP receptors in adipose tissue, increasing lipid clearance, preventing fat storage, and enhancing insulin sensitivity in muscle cells.
Smooths out daily blood glucose fluctuations, preventing insulin spikes and the low-blood-sugar “crashes” that trigger sugar cravings.
Next-Gen Metabolic Science
First-generation weight loss peptides like Semaglutide target only GLP-1 receptors, often causing nausea and energy slumps. Tirzepatide’s dual-action formula delivers higher fat loss with maximum physical comfort.


Your Transformation Timeline
Instant reduction in appetite and total food noise within 12–24 hours. Rapid reduction in bloating and fluid retention.
Predictable weekly fat loss (1–2 kg per week). Noticeable loosening of clothing around the waist, hips, and midsection.
Major reduction in body fat percentage, improved metabolic markers, stabilized insulin sensitivity, and effortless portion control.
Choose a ready-made set with this exact pen format and see the saving on the pair.
Save 300.000 IDRTirzepatide 30 mg + MOTS-C 32 mg
Tirzepatide 30 mg with MOTS-C 32 mg. The lower-total-content Tirzepatide option in our bundle range.
Save 500.000 IDRTirzepatide 60 mg + MOTS-C 32 mg
Tirzepatide 60 mg with MOTS-C 32 mg. Twice the Tirzepatide contents of CONTROL MODE.
Tirzepatide is a dual GLP-1 and GIP receptor agonist, whereas Semaglutide activates only GLP-1 receptors. The addition of GIP receptor activity accelerates fat loss, optimizes glucose metabolism, and significantly reduces side effects like nausea.
The 30mg variant (Yellow Pen) is ideal for beginners and standard titration protocols (e.g. 2.5mg to 5mg weekly). The 60mg variant (Orange Pen) is designed for advanced users requiring higher weekly doses (7.5mg to 15mg weekly) or longer protocol duration.
Clinical studies demonstrate an average body weight reduction of 15% to 22% over a full protocol. Most users experience steady, predictable fat loss of 1 to 2 kg per week without feeling deprived or fatigued.
Thanks to its GIP receptor co-agonism, Tirzepatide is significantly better tolerated than older single GLP-1 peptides. Any mild digestive adjustment in Week 1 can be minimized by following our gradual dose titration guide and staying well-hydrated.
The Tirzepatide 30 mg pen provides up to 8 weeks of use; the 60 mg pen provides up to 12 weeks. The actual duration depends on the amount and frequency prescribed for you. Follow the individual product instructions for storage and use after opening.
Yes. Our pens come pre-filled with liquid Tirzepatide solution. Each package includes eight ultra-thin 31G needles and an administration guide—no manual reconstitution or sterile water mixing is required.
Absolutely. Stacking with MOTS-C protects your baseline metabolic rate and boosts workout energy, NAD+ maintains cellular energy, and CJC + Ipamorelin prevents muscle loss during caloric deficits.
Standard protocols begin at 2.5 mg once weekly for the first 4 weeks to allow your body to adapt. Dose increases can then occur incrementally (e.g. 5 mg, 7.5 mg) depending on your individual progress and goals.
Once your order is saved, WhatsApp opens automatically with your order details pre-filled. Review the message and tap Send to arrange payment and express cold-chain delivery.
Store your pen refrigerated at 2°C–8°C to maintain maximum peptide stability. We deliver all orders across Bali in temperature-controlled thermal boxes with gel ice packs to ensure 100% integrity upon delivery.